Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Glaucoma
What concentration/dose of mitomycin C do you use for trabeculectomies and XENs and how do you titrate based on patient factors?
Related Questions
How has your use of SLT changed given the 6-year results of the LiGHT trial?
What is your preferred approach to managing a patient with tube exposure?
What has been your experience both intra-op and post-op with different non-valved implants (Baerveldt vs. Clearpath)?
Which patients are good candidates for micropulse CPC?
How do you approach tube shunt placement in very high myopes with thin sclera?
In patients with glaucoma who are not ideal candidates for goniotomy, angle stenting, tubes, or trabeculectomy, does the use of AlloFlo provide safe and predictable IOP control compared to other surgical options?
What is the most appropriate next step for a patient experiencing prolonged hypotony following Ahmed glaucoma valve implantation and unsuccessful medical management?
What is your approach to managing failed trabeculectomies with scarring but controlled IOP?
How do you decide the best way to treat glaucoma in patients with ICE syndrome given their higher risk of surgical failure and corneal complications?
How would you approach choosing a MIGS procedure for a patient with mild glaucoma with progressively worsening PAS undergoing cataract surgery?
